Drug Approvals
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 49–60 of 665 articles
Lenacapavir PrEP shows high HIV-prevention efficacy in Gilead’s Phase 3 trials
oncology · 7 min
Dr. Sarah MitchellVertex launches Journavx after FDA approval for acute pain
FDA · oncology · 9 min
Dr. Sarah MitchellAstraZeneca and Daiichi Sankyo datopotamab deruxtecan hits lung cancer endpoint
oncology · 8 min
Dr. Sarah MitchellFDA approves Keytruda adjuvant NSCLC use in early-stage lung cancer
FDA · oncology · 7 min
Dr. Sarah MitchellFDA approves Keytruda adjuvant NSCLC use: what Merck investors should watch
FDA · oncology · 7 min
Dr. Sarah MitchellNovo Nordisk CagriSema Phase 3 Obesity Results Signal Key Catalyst
EMA · oncology · 5 min
Dr. Sarah MitchellGene Therapy FDA Approval for Rare Disease: Updated List and Analysis
FDA · rare disease · 5 min
Dr. Sarah MitchellFacet Life Sciences Appoints Frank Closurdo as VP, Commercial Services
5 min
Dr. Sarah MitchellAmneal Romidepsin FDA Approval: B2B Analysis for BD Teams and Investors
FDA · 6 min
Dr. Sarah MitchellSummit Pipeline Approvals and Competitive Outlook: 2023-2024 Update
6 min
Dr. Sarah MitchellListeria Outbreaks 2026: FDA and CDC Soft Cheese Recall Analysis for Pharma
FDA · oncology · 6 min
Dr. Sarah Mitchell5 Notable Oncology FDA Approvals Granted in May: A B2B Analysis
FDA · oncology · 6 min
Dr. Sarah MitchellExplore intelligence